kc-8k_form.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C.  20549

FORM 8-K

_________________________________________


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934


Date of Report: July 23, 2007
(Date of earliest event reported)


KIMBERLY-CLARK CORPORATION
(Exact name of registrant as specified in its charter)


Delaware
1-225
39-0394230
     
(State or other jurisdiction
(Commission File
(IRS Employer
of incorporation)
Number)
Identification No.)
     

 
P.O. Box 619100, Dallas, Texas
75261-9100
(Address of principal executive offices)
(Zip Code)

 
(972) 281-1200
(Registrant’s telephone number, including area code)

 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

______________________________________


Item 5.02.
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.


On July 23, 2007, the Board of Directors of Kimberly-Clark Corporation (the “Corporation”) elected Mr. Ian C. Read to the Board of Directors, effective August 15, 2007.  Mr. Read is a Senior Vice President of Pfizer, Inc. and President of its Worldwide Pharmaceutical Operations. Mr. Read also was appointed to the Audit Committee of the Corporation’s Board of Directors effective August 15, 2007. Mr. Read will participate in the Corporation’s Outside Director Compensation Plan.

A copy of the news release announcing the election of Mr. Read to the Corporation’s Board of Directors is attached hereto as Exhibit 99.1.


Item 9.01.
Financial Statements and Exhibits.

  (d) Exhibits

 Exhibit 99.1 News release issued by Kimberly-Clark Corporation on July 25, 2007.





SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


   KIMBERLY-CLARK CORPORATION



Date:  July 26, 2007
By:  /s/ Timothy C. Everett                     
 
Timothy C. Everett
 
Vice President and Secretary
   





EXHIBIT INDEX

99.1
News release issued by Kimberly-Clark Corporation on July 25, 2007.